Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies.
Konstantin PenkovIgor BondarenkoDaria Viktorovna SaenkoYaroslav KulyabaJun GuoYi GongNoboru YamamotoYevhen Stepanovych HotkoVasyl BoykoNatalya Vladimirovna FadeevaGrygorii Mykolaiovych UrsolHee Kyung AhnNikolay Viktorovich KislovChia-I ShenCraig DavisKarey KowalskiElisabete MichelonDmitri PavlovTomoko HirohashiByoung Chul ChoPublished in: Therapeutic advances in medical oncology (2024)
NCT04181788 (ClinicalTrials.gov); 2019-003818-14 (EudraCT).